Frauke Christ

Frauke Christ

Auto-generated profile, based on publicly available information

Frauke Christ

Laboratory for Molecular Virology and Gene Therapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Flanders, Belgium

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2010 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
FCFrauke Christ
Frauke Christ
AVArnout Voet
Arnout Voet
AMArnaud Marchand
Arnaud Marchand
SNStefan Nicolet
Stefan Nicolet
BDBelete Desimmie
Belete Desimmie
ZDZeger Debyser
Zeger Debyser

1 August 2008 in Current Biology
Verified
Journal Article
Closed access
FCFrauke Christ
Frauke Christ
WTWannes Thys
Wannes Thys
JRJan De Rijck
Jan De Rijck
RGRik Gijsbers
Rik Gijsbers
AAAlberto Albanese
Alberto Albanese
ZDZeger Debyser
Zeger Debyser

1 July 2005 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SEStéphane Emiliani
Stéphane Emiliani
AMAurélie Mousnier
Aurélie Mousnier
KBKatrien Busschots
Katrien Busschots
MMMarlène Maroun
Marlène Maroun
BMBénédicte Van Maele
Bénédicte Van Maele
RBRichard Benarous
Richard Benarous
The insertion of a DNA copy of its RNA genome into a chromosome of the host cell is mediated by the viral integrase with the help of mostly uncharacterized cellular cofactors. We have recently described that the transcriptional co-activator LEDGF/p75 strongly interacts with HIV-1 integrase. Here we show that interaction of HIV-1 integrase with LEDGF/p75 is important for viral replication. Using multiple approaches including two-hybrid interaction studies, random and directed mutagenesis, we could demonstrate that HIV-1 virus harboring a single mutation that disrupts integrase-LEDGF/p75 interaction, resulted in defective HIV-1 replication. Furthermore, we found that LEDGF/p75 tethers HIV-1 integrase to chromosomes and that this interaction may be important for the integration process and the replication of HIV-1.

1 May 2005 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
KBKatrien Busschots
Katrien Busschots
JVJo Vercammen
Jo Vercammen
SEStéphane Emiliani
Stéphane Emiliani
RBRichard Benarous
Richard Benarous
YEYves Engelborghs
Yves Engelborghs
ZDZeger Debyser
Zeger Debyser
We have previously shown that the p75 isoform of the transcriptional co-activator lens epithelium-derived growth factor (LEDGF) interacts tightly with human immunodeficiency virus (HIV)-1 integrase (IN) and is essential for nuclear targeting of this protein in human cells (Cherepanov, P., Maertens, G., Proost, P., Devreese, B., Van Beeumen, J., Engelborghs, Y., De Clercq, E., and Debyser, Z. (2003) J. Biol. Chem. 278, 372–381; Maertens, G., Cherepanov, P., Pluymers, W., Busschots, K., De Clercq, E., Debyser, Z., and Engelborghs, Y. (2003) J. Biol. Chem. 278, 33528–33539). Here the interaction between recombinant LEDGF/p75 and HIV-1 IN was examined in a pull-down binding test. LEDGF/p75 was shown to increase the solubility of HIV-1 IN. Next, fluorescent correlation spectroscopy was used to measure the interaction of LEDGF/p75 or the complex of HIV-1 IN and LEDGF/p75 with a specific double-stranded DNA oligonucleotide. Whereas LEDGF/p75 displayed only a moderate affinity for DNA, it strongly promoted the binding of HIV-1 IN to DNA. This effect was specific for the p75 isoform of LEDGF and was not seen with p52. In the pull-down assay LEDGF/p75 interacted with HIV-1, HIV-2, and feline immunodeficiency virus IN, but not with the IN of human T-cell lymphotropic virus type 2, Moloney murine leukemia virus, or Rous sarcoma virus. These results strongly suggest that the interaction of LEDGF/p75 with IN is specific to lentiviridae. LEDGF/p75 stimulated the binding of HIV-1 and HIV-2 IN, but not Moloney murine leukemia virus or Rous sarcoma virus IN, to an aspecific DNA. These results provide supporting evidence for our hypothesis that LEDGF/p75 plays a role in the tethering of lentiviral IN to the chromosomal DNA.

15 February 2006 in Journal of Virology
Verified
Journal Article
Closed access
PDF file
LVLinos Vandekerckhove
Linos Vandekerckhove
FCFrauke Christ
Frauke Christ
BMBénÉdIcte Van Maele
BénÉdIcte Van Maele
JRJan De Rijck
Jan De Rijck
RGRik Gijsbers
Rik Gijsbers
ZDZeger Debyser
Zeger Debyser
After identifying the interaction between the transcriptional coactivator lens epithelium-derived growth factor (LEDGF/p75) and the human immunodeficiency virus type 1 (HIV-1) integrase (IN), we have now investigated the role of LEDGF/p75 during HIV replication. Transient small interfering RNA-mediated knockdown of LEDGF/p75 in HeLaP4 cells resulted in a three- to fivefold inhibition of HIV-1 (strain NL4.3) replication. Quantitative PCR was used to pinpoint the replication block to the integration step. Next, polyclonal and monoclonal HeLaP4-derived cell lines were selected with a stable knockdown of LEDGF/p75 mediated by a lentiviral vector (lentivector) encoding a short hairpin RNA (shRNA) targeting this protein. Cell lines stably transduced with a lentivector encoding an unrelated hairpin or a double-mismatch hairpin served as controls. Again, a two- to fourfold reduction of HIV-1 replication was observed. The extent of LEDGF/p75 knockdown closely correlated with the reduction of HIV-1 replication. After the back-complementation of LEDGF/p75 in the poly- and monoclonal knockdown cell lines using an shRNA-resistant expression plasmid, viral replication was restored to nearly wild-type levels. The Q168A mutation in integrase has been shown to interfere with the interaction with LEDGF/p75 without reducing the enzymatic activity. Transduction by HIV-1-derived lentivectors carrying the Q168A IN mutant was severely hampered, pointing again to a requirement for LEDGF/p75. Altogether, our data validate LEDGF/p75 as an important cellular cofactor for HIV integration and as a potential target for antiviral drug development.

1 February 2006 in Trends in Biochemical Sciences
Verified
Journal Article
Closed access
BMBénédicte Van Maele
Bénédicte Van Maele
KBKatrien Busschots
Katrien Busschots
LVLinos Vandekerckhove
Linos Vandekerckhove
FCFrauke Christ
Frauke Christ
ZDZeger Debyser
Zeger Debyser